ID: ALA354972

Max Phase: Preclinical

Molecular Formula: C14H11ClN2

Molecular Weight: 242.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Clc1cccc(Cc2nc3ccccc3[nH]2)c1

Standard InChI:  InChI=1S/C14H11ClN2/c15-11-5-3-4-10(8-11)9-14-16-12-6-1-2-7-13(12)17-14/h1-8H,9H2,(H,16,17)

Standard InChI Key:  IQJMWFVIAPBMBL-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 242.71Molecular Weight (Monoisotopic): 242.0611AlogP: 3.81#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.24CX Basic pKa: 5.88CX LogP: 3.82CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.73Np Likeness Score: -1.61

References

1. Murray M, Ryan AJ, Little PJ..  (1982)  Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.,  25  (8): [PMID:7120277] [10.1021/jm00350a002]
2. Boggu P, Venkateswararao E, Manickam M, Kwak D, Kim Y, Jung SH..  (2016)  Exploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB.,  24  (8): [PMID:26976506] [10.1016/j.bmc.2016.03.012]

Source